Chante Aksut, MD
Dermatology · Hoover, ALNPI 1942696232
Payments from drug & device makers
Across 142 payments — averaging $20.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$668
- Novartis$665
- Sanofi$382
- Johnson & Johnson$195
- LEO Pharma Inc.$160
- Lilly USA, LLC$142
- plus $685 from 16 others
What the payments were for
- Speaking & faculty fees$161%
- Food & beverage$2,88099%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 39 | $668 |
| Novartis | 30 | $665 |
| Sanofi | 17 | $382 |
| Johnson & Johnson | 9 | $195 |
| LEO Pharma Inc. | 7 | $160 |
| Lilly USA, LLC | 7 | $142 |
| UCB, Inc. | 4 | $113 |
| Sun Pharmaceutical Industries Inc. | 5 | $108 |
| Almirall LLC | 3 | $76 |
| Incyte Corporation | 3 | $52 |
| Galderma Laboratories, L.p. | 3 | $49 |
| Verrica Pharmaceuticals Inc. | 3 | $45 |
| Regeneron Healthcare Solutions, Inc. | 1 | $40 |
| Journey Medical Corporation | 2 | $38 |
| Pfizer | 2 | $38 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| Amgen | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $16 |
| Irhythm Technologies, Inc. | 1 | $16 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
| VYNE Pharmaceuticals Inc. | 1 | $14 |
How this compares
$2,897 in reported general payments places this provider in the 40th percentile of 168 dermatology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 40 | $2,964 |
| Fluorouracil | 15 | $1,104 |
| Ketoconazole | 46 | $846 |
| Triamcinolone Acetonide | 41 | $474 |
| Hydrocortisone | 24 | $117 |
| Mupirocin | 15 | $107 |
| Prednisone | 11 | $65 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Hoover
- Vlada GroysmanHoover$7.2M
- Holly GunnHoover$35K
- Katherine HuntHoover$12K
- Boni ElewskiBirmingham$5.5M
- James KrellBirmingham$4M
- John VanloockMobile$1.4M
- Tiffany MayoBirmingham$1.4M
- Melanie AppellBirmingham$983K
- Julie HarperBirmingham$920K
- Eric BaumGadsden$896K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.